Recent Advances in Psychopharmacology of Depression

References

• Amsterdam J., Brunswick D., Mendels J. The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels. American Journal of Psychiatry 1980; 137: 653–662
   PubMed Web of Science ®Google Scholar
• Asberg M., Cronholm B., Sjoqvist F., Tuck D. Serotonin depression — a biochemical subgroup within the affective disorders. Science 1980; 191: 478–480
   Google Scholar
• Brown W., Johnston R., Mayfield D. The 24 hour dexamethasone suppression test in a clinical setting: relationship to diagnosis, symptoms and responses to treatment. American Journal of Psychiatry 1979; 136: 543–547
   PubMedGoogle Scholar
• Burrows G., Davies B., Norman T., Maguire K., Scoggins B. Should plasma level monitoring of tricyclic antidepressants be introduced in clinical practice?. Communications in Psychopharmacology 1978; 2: 393–408
   Google Scholar
• Butler P., Besser G. Pituitary-adrenal function in severe depressive illness. Lancet 1968; 1: 1234–1236
   Google Scholar
• Carpenter W., Bunney W. Adrenal cortical activity in depressive illness. American Journal of Psychiatry 1971; 128: 31–40
   PubMed Web of Science ®Google Scholar
• Carroll B. Plasma cortisol levels in depression. Depressive Illness — Some Research Studies, B. Davies, B. Carroll, R. Mowbray. Charles Thomas, Illinois 1972
   Google Scholar
• Carroll B. Prediction of treatment outcome with lithium. Lithium: Controversies and Unresolved Issues, T. Cooper, S. Gershon, N. Kline, M. Schou. Excerpta Medica, Amsterdam 1979
   Google Scholar
• Carroll B., Curtis G., Mendels J. Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. Archives of General Psychiatry 1976a; 33: 1039–1044
   PubMed Web of Science ®Google Scholar
• Carroll B., Curtis G., Mendels J. Neuroendocrine regulation in depression. II. Discrimination of depressed from non-depressed patients. Archives of General Psychiatry 1977b; 33: 1051–1058
   Google Scholar
• Carroll B., Greden J., Rubin R., Haskett R., Fienberg M., Schtiengart D. Neurotransmitter mechanisms of neuroendocrine disturbances in depression. Acta Endocrinologica 1978; 14, Suppl. 220
   Google Scholar
• Carroll B., Greden J., Fienberg M. Neuroendocrine disturbances and the diagnosis and etiology of endogenous depression. Lancet 1980; 1: 321–322
   Google Scholar
• Checkley S. Corticosteroid and growth hormone response to methylamphetamine in depressive illness. Psychological Medicine 1979; 9: 107–116
   PubMed Web of Science ®Google Scholar
• Checkley S., Crammer J. Hormone responses to methylamphetamine in depression. British Journal of Psychiatry 1977; 131: 582–586
   PubMed Web of Science ®Google Scholar
• Coppen A., Rama Rao V., Ruthven C., Goodwin B., Sandler M. Urinary 4 hydroxy-3-methoxyphenylglycol is not a predictor for clinical response to amitriptyline in depressive illness. Psychopharmacology 1979; 641: 95–97
   Google Scholar
• Dunner D., Meltzer H., Fieve R. Clinical correlates of the lithium pump. American Journal of Psychiatry 1978; 135: 1062–1064
   Google Scholar
• Gold P., Goodwin F. Urinary Free Cortisol in Depression and Mania. Presented at the 130th Annual Meeting of the American Psychiatric Association, Toronto, Canada, May, 1977; 2–6
   Google Scholar
• Gold M., Pottash A., Extein I., Sweeney D. Dexamethasone suppression tests in depression and response to treatment. Lancet 1980; 1: 1190
   PubMed Web of Science ®Google Scholar
• Goldberg T. Dexamethasone suppression test as indication of safe withdrawal of antidepressant therapy. Lancet 1980; 1: 376
   Google Scholar
• Greden J., Albala A., Haskett R., James N., Goodman L., Steiner M., Carroll B. Normalisation of dexamethasone suppression test. A laboratory index of recovery from endogenous depression. Biological Psychiatry 1980; 15: 449–459
   PubMed Web of Science ®Google Scholar
• Hullin R. Minimum effective plasma lithium levels for long-term preventive treatment of recurrent affective disorders. Lithium: Controversies and Unresolved Issues, T. Cooper, S. Gershon, N. Kline, M. Schou. Excerpta Medica, Amsterdam 1978
   Google Scholar
• Hullin R., Coley V., Birch N., Thomas T., Morgan D. Renal function after long-term treatment with lithium. British Medical Journal 1979; 1: 1457–1459
   PubMedGoogle Scholar
• Johnson G. Endocrine dysfunction in depression. Handbook of Endocrinology and Psychiatry, G. Burrows, P. Beumont. Elsevier/North-Holland, (In press)
   Google Scholar
• Johnson G., Hunt G., Jackson D., Richards T., Kwan E. Pharmacokinetics of standard and sustained-release (Priadel) lithium carbonate preparations. Medical Journal of Australia 1979; 2: 382
   Google Scholar
• Kreiger D. Factors influencing the circadian periodicity of adrenal steroid levels. Transactions New York Academy of Science 1970; 32: 316–328
   Google Scholar
• Maas J. W. Biogenic amines and depression. Biochemical and pharmacological separations of two types of depression. Archives of General Psychiatry 1975; 32: 1357
   PubMed Web of Science ®Google Scholar
• Mendels J., Frazer A. Intracellular lithium concentration and clinical response. Towards a membrane theory of depression. Journal of Psychiatric Research 1973; 10: 9–18
   PubMed Web of Science ®Google Scholar
• Mendlewicz J., Linkowski P., Branchey L., Weinberg U., Weitzman E., Branchey M. Abnormal 24 hour pattern of melatonin secretion in depression. Lancet 1979; 2: 1362
   PubMed Web of Science ®Google Scholar
• Sacchetti E., Allaria E., Negri F., Biondi P. A., Smeraldi E., Azzullo C. L. 3-Methoxy-4-hydroxyphenylglycol and primary depression: clinical and pharmacological considerations. Biological Psychiatry 1979; 14: 473–484
   Google Scholar
• Schildkraut J. J. Norepinephrine metabolites and biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings. American Journal of Psychiatry 1973; 130: 695
   Google Scholar
• Shopsin B., Gershon S. Plasma cortisol response to dexamethasone suppression in depressed and control patients. Archives of General Psychiatry 1971; 24: 320–326
   PubMed Web of Science ®Google Scholar
• Stokes P. Studies on the control of adrenal corticol function in depression. Recent Advances in the Psychobiology of the Depressive Illness, T. Williams, J. Shield, M. Katz. U.S. Govt. Printing Office, Washington, D.C. 1972
   Google Scholar
• Traskman L., Åsberg M., Bertilsson L. Serotonin and Noradrenaline Uptake Inhibitors in the Treatment of Depressions Relationship to SHIAA in Spinal Fluid. Presented at International Symposium on Recent Advances in the Treatment of Depression. Corfu. April, 1980; 16–18
   Google Scholar
• Van Praag H. M. New evidence of serotonin-deficient depressions. Neuropsychobiology 1977; 3: 56–63
   Google Scholar
• Vestergaard P., Amdisen A., Hansen H., Schou M. Lithium treatment and kidney function. A survey of 237 patients in long-term treatment. Acta Psychiatrica Scandinavica 1979; 60: 504–520
   PubMed Web of Science ®Google Scholar
• Wetterberg L., Beck-Friis J., Aperia B., Petterson U. Melatonin/cortisol ratio in depression. Lancet 1979; 2: 1361
   Web of Science ®Google Scholar
• Ziegler V., Co B., Biggs J. Plasma nortriptyline levels and ECG findings. American Journal of Psychiatry 1977; 134: 441–443
   PubMed Web of Science ®Google Scholar